US equities |
SPCX $169.00 ▲+6.32% NVDA $237.43 ▲+1.49% MU $1,065.44 ▼-0.88% TSLA $379.64 ▲+2.44% MSFT $524.82 ▲+1.41% SNDK $1,715.26 ▼-0.28% INTC $116.88 ▼-2.06% META $744.14 ▲+2.21%
FinancialContent

Articles published by argenx

News headline image
argenx Announces VYVGART™ Approval in Japan for the Treatment of Generalized Myasthenia Gravis
From argenx
Via Business Wire
Tickers ARGX
News headline image
argenx Highlights Strategic Priorities for 2022
From argenx
Via Business Wire
Tickers ARGX